{"id":129326,"date":"2021-01-22T00:00:00","date_gmt":"2023-03-15T11:07:49","guid":{"rendered":"https:\/\/www.mdbriefcase.com\/course\/proteger-vos-patients-atteints-du-diabete-de-type-2\/"},"modified":"2023-05-02T08:52:26","modified_gmt":"2023-05-02T12:52:26","slug":"proteger-vos-patients-atteints-du-diabete-de-type-2","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/","title":{"rendered":"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2"},"content":{"rendered":"<p>L\u2019introduction des nouveaux agents antihyperglyc\u00e9miants, incluant les agonistes des r\u00e9cepteurs du GLP-1 (AR GLP-1) et les inhibiteurs des SGLT2 (iSGLT2), a sensiblement \u00e9largi les opportunit\u00e9s d\u2019am\u00e9liorer les issues cliniques chez les patients atteints de diab\u00e8te de type 2.\n<\/p>\n<p>Ce programme aide les m\u00e9decins de soins primaires \u00e0 naviguer le paysage changeant du diab\u00e8te, au-del\u00e0 de la seule ma\u00eetrise de la glyc\u00e9mie.\n<\/p>\n<p><strong>Les donn\u00e9es cliniques \u00e9tayant l\u2019efficacit\u00e9 des agents antihyperglyc\u00e9miantspour abaisser la glyc\u00e9mie et offrir une protection cardiovasculaire <\/strong>seront<strong> <\/strong>illustr\u00e9es au moyen d\u2019une formation bas\u00e9e sur des cas de patients, dans le but d\u2019accro\u00eetre la confiance du clinicien lorsqu\u2019il vient le temps d\u2019intensifier le traitement conform\u00e9ment aux plus r\u00e9centes recommandations de Diab\u00e8te Canada.\n<\/p>\n<hr>\n<p>Ce programme a \u00e9t\u00e9 \u00e9labor\u00e9 conjointement avec M3 (EU) Ltd.\n<\/p>\n<p>Ce programme de formation a fait l\u2019objet d\u2019une bourse \u00e0 vis\u00e9e \u00e9ducative ou d\u2019un soutien en nature de la part de Novo Nordisk.<\/p>","protected":false},"featured_media":441500,"comment_status":"closed","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-129326","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2 - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/proteger-vos-patients-atteints-du-diabete-de-type-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2 - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"L\u2019introduction des nouveaux agents antihyperglyc\u00e9miants, incluant les agonistes des r\u00e9cepteurs du GLP-1 (AR GLP-1) et les inhibiteurs des SGLT2 (iSGLT2), a sensiblement \u00e9largi les opportunit\u00e9s d\u2019am\u00e9liorer les issues cliniques chez les patients atteints de diab\u00e8te de type 2. Ce programme aide les m\u00e9decins de soins primaires \u00e0 naviguer le paysage changeant du diab\u00e8te, au-del\u00e0 de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/proteger-vos-patients-atteints-du-diabete-de-type-2\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T12:52:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/01\/protecting-patients-with-t2d_LP-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/\",\"name\":\"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2 - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/protecting-patients-with-t2d_LP-3.jpg\",\"datePublished\":\"2023-03-15T11:07:49+00:00\",\"dateModified\":\"2023-05-02T12:52:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/protecting-patients-with-t2d_LP-3.jpg\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/protecting-patients-with-t2d_LP-3.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/proteger-vos-patients-atteints-du-diabete-de-type-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mdbriefcase.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2 - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/proteger-vos-patients-atteints-du-diabete-de-type-2\/","og_locale":"fr_CA","og_type":"article","og_title":"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2 - MDBriefCase","og_description":"L\u2019introduction des nouveaux agents antihyperglyc\u00e9miants, incluant les agonistes des r\u00e9cepteurs du GLP-1 (AR GLP-1) et les inhibiteurs des SGLT2 (iSGLT2), a sensiblement \u00e9largi les opportunit\u00e9s d\u2019am\u00e9liorer les issues cliniques chez les patients atteints de diab\u00e8te de type 2. Ce programme aide les m\u00e9decins de soins primaires \u00e0 naviguer le paysage changeant du diab\u00e8te, au-del\u00e0 de [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/proteger-vos-patients-atteints-du-diabete-de-type-2\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T12:52:26+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/01\/protecting-patients-with-t2d_LP-3.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/","url":"https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/","name":"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2 - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/01\/protecting-patients-with-t2d_LP-3.jpg","datePublished":"2023-03-15T11:07:49+00:00","dateModified":"2023-05-02T12:52:26+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/01\/protecting-patients-with-t2d_LP-3.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/01\/protecting-patients-with-t2d_LP-3.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/proteger-vos-patients-atteints-du-diabete-de-type-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Prot\u00e9ger vos patients atteints du diab\u00e8te de type 2"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/129326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=129326"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/129326\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/441500"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=129326"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=129326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}